Holdings

Krensavage Asset Management, LLC

As of Sep 30, 2026, Krensavage Asset Management, LLC reported 18 positions worth US$225M. Largest: Enanta Pharmaceuticals, Inc., United Therapeutics Corporation and BioMarin Pharmaceutical Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Enanta Pharmaceuticals, Inc.2.87MUS$37.8Mno changeSep 30, 2026
United Therapeutics Corporation66,282US$35.9M−3,000Sep 30, 2026
BioMarin Pharmaceutical Inc.525KUS$31.5Mno changeSep 30, 2026
Abbott Laboratories200KUS$19.8Mno changeSep 30, 2026
Exelixis, Inc.299KUS$17.5M−71,300Sep 30, 2026
Ultragenyx Pharmaceutical Inc.1.14MUS$17.1M+750KSep 30, 2026
Supernus Pharmaceuticals, Inc.351KUS$15.1M+70,000Sep 30, 2026
Sanofi SA334KUS$13.8M+10,000Sep 30, 2026
Embecta Corp.1.14MUS$6.43Mno changeSep 30, 2026
Ardelyx, Inc.1.82MUS$6.21M+1.28MSep 30, 2026